Diane Havlir
Diane Havlir
Geverifieerd e-mailadres voor ucsf.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Prevention of HIV-1 infection with early antiretroviral therapy
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England journal of medicine 365 (6), 493-505, 2011
76762011
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
JK Wong, M Hezareh, HF Günthard, DV Havlir, CC Ignacio, CA Spina, ...
Science 278 (5341), 1291-1295, 1997
23391997
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
RM Gulick, JW Mellors, D Havlir, JJ Eron, C Gonzalez, D McMahon, ...
New England Journal of Medicine 337 (11), 734-739, 1997
23241997
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
V Appay, PR Dunbar, M Callan, P Klenerman, GMA Gillespie, L Papagno, ...
Nature medicine 8 (4), 379-385, 2002
18012002
The end of AIDS: HIV infection as a chronic disease
SG Deeks, SR Lewin, DV Havlir
The Lancet 382 (9903), 1525-1533, 2013
16032013
Antiretroviral therapy for the prevention of HIV-1 transmission
MS Cohen, YQ Chen, M McCauley, T Gamble, MC Hosseinipour, ...
New England Journal of Medicine 375 (9), 830-839, 2016
11702016
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
V Appay, DF Nixon, SM Donahoe, GMA Gillespie, T Dong, A King, ...
The Journal of experimental medicine 192 (1), 63-76, 2000
10862000
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
ZQ Zhang, T Schuler, M Zupancic, S Wietgrefe, KA Staskus, KA Reimann, ...
Science 286 (5443), 1353-1357, 1999
10751999
Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19
M Gandhi, DS Yokoe, DV Havlir
New England Journal of Medicine 382 (22), 2158-2160, 2020
9552020
Class-sparing regimens for initial treatment of HIV-1 infection
SA Riddler, R Haubrich, AG DiRienzo, L Peeples, WG Powderly, ...
New England Journal of Medicine 358 (20), 2095-2106, 2008
8272008
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
DD Richman, D Havlir, J Corbeil, D Looney, C Ignacio, SA Spector, ...
Journal of virology 68 (3), 1660-1666, 1994
7371994
Tuberculosis in patients with human immunodeficiency virus infection
DV Havlir, PF Barnes
New England journal of medicine 340 (5), 367-373, 1999
7021999
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
DV Havlir, MA Kendall, P Ive, J Kumwenda, S Swindells, SS Qasba, ...
New England Journal of Medicine 365 (16), 1482-1491, 2011
6582011
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
B Grinsztejn, MC Hosseinipour, HJ Ribaudo, S Swindells, J Eron, ...
The Lancet infectious diseases 14 (4), 281-290, 2014
5092014
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, AC Collier, MS Hirsch, ...
Jama 286 (2), 171-179, 2001
4492001
Prophylaxis against Disseminated Mycobacterium avium Complex with Weekly Azithromycin, Daily Rifabutin, or Both
DV Havlir, MP Dubé, FR Sattler, DN Forthal, CA Kemper, MW Dunne, ...
New England Journal of Medicine 335 (6), 392-398, 1996
4091996
Viral dynamics of acute HIV-1 infection
SJ Little, AR McLean, CA Spina, DD Richman, DV Havlir
The Journal of experimental medicine 190 (6), 841-850, 1999
3771999
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
D Havlir, SH Cheeseman, M Mclaughlin, R Murphy, A Erice, SA Spector, ...
Journal of Infectious Diseases 171 (3), 537-545, 1995
3721995
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
MC Strain, SJ Little, ES Daar, DV Havlir, HF Günthard, RY Lam, OA Daly, ...
The Journal of infectious diseases 191 (9), 1410-1418, 2005
3482005
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
DV Havlir, NS Hellmann, CJ Petropoulos, JM Whitcomb, AC Collier, ...
Jama 283 (2), 229-234, 2000
3392000
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20